Anti-tumor Drug Market Outlook to 2023 – Roche, Novartis, Celgene, Bristol-, Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co, Sanofi, Bayer, Biogen Idec, Eisai, Teva, Otsuka

Nov 2018, New York USA (News)- Over the next five years, Research Reports Inc. projects that Anti-tumor Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017. Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
In China, antitumor drugs are also the key areas of concern for many enterprises. Such as Jiangsu Hengrui, Qilu Pharmaceutical and other well-known domestic enterprises in the anti-tumor drugs have invested a lot of money, there are many innovative anti-cancer drugs into the clinical research stage. In the meantime, there has been “explosive” growth in the development of molecularly targeted drugs, with at least hundreds of drugs under development, and it is conceivable that the market will be quite crowded in the next five to 10 years. Therefore, domestic enterprises should fully understand the feasibility of the project and the fierce market competition that they may face in the future.

China’s bio-pharmaceutical industry already has a good foundation; from the national level to local governments at all levels continue to step up efforts to support the development of bio-pharmaceutical industry. The output value of the pharmaceutical industry maintained a growth rate of 20% during the 12th Five-Year Plan period. In 2013, the total output value of the pharmaceutical industry reached 2.1 trillion yuan. However, compared with the bio-pharmaceutical industry in the advanced countries in the world, there is still a huge gap between the biomedical industry in our country and the demand for building an overall well-to-do society. Mainly manifested in: small-scale enterprises, more than 10 billion yuan enterprises and more than one billion yuan less; independent innovation ability is weak, many varieties of imitation with independent intellectual property rights of the few species; restrict some of the long-term development of biomedical industry , Deep-seated problems still exist.

Major Market Players
• Cyanotech
• Fuji
• BGG
• Parry Nutraceuticals
• Algatechnologies
• Biogenic
• Jingzhou Anti-tumor Drug
• Yunnan Alphy Biotech
• ADM
• Piveg

Directly Get Corporate Report with 20% Discount (Use Code “DISC20”): https://researchreportsinc.com/checkout/?add-to-cart=176284&&attribute_pa_choose-license=single-user&&quantity=1

To calculate the market size, Research Reports Inc. considers value generated from the sales of the following segments:
Segmentation by product type:
• Cytotoxic Drugs
• Non-cytotoxic Drugs
Segmentation by application:
• Alkylating Agents
• Anti-metabolism Drugs
• Platinum Antineoplastic Agents
• Anthracycline antitumor drugs
• Microtubule Stabilizer
• Endocrine Therapy Drugs
• Immunotherapy Drugs
• Gene Therapy Drugs
• Targeted Antineoplastic Drugs

Research objectives
To study and analyze the global Anti-tumor Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Anti-tumor Drug market by identifying its various sub-segments.
Focuses on the key global Anti-tumor Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-tumor Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

About Us:
Research Reports Inc. is one of the leading destinations for market research reports across all industries, companies, and technologies. Our repository features an exhaustive list of market research reports from thousands of publishers worldwide.

Contact Us:
David
Sales Manager,
US / Canada Toll Free: +18554192424
UK: +4403308087757
Email: sales@researchreportsinc.com

This release was published on openPR.